BCL6 and diffuse large B-cell lymphoma: The findings of the study demonstrated that DC-Exo encapsulating BCL6 siRNA effectively inhibited the proliferation of diffuse large B-cell lymphoma (DLBCL) in vitro and significantly suppressed tumor growth in murine models without exhibiting notable toxicity (Figure 4 and Figure 5) [55].